![Rafi Kazandjian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Rafi Kazandjian
Entité | Type d'entité | Industrie | |
---|---|---|---|
Eyevensys SAS
![]() Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rafi Kazandjian via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Padua | College/University | Doctorate Degree | |
Assobiotec
![]() Assobiotec Miscellaneous Commercial ServicesCommercial Services Assobiotec is an organization that represents approximately 130 companies and technological and scientific parks in the biotech sector. Assobiotec is based in Milan, Italy. The Italian company focuses on various areas such as health, agriculture, environment, and industrial processes. The private company was founded in 1986, and the CEO is Leonardo Vingiani. | Miscellaneous Commercial Services | Director/Board Member | |
Anabasis SRL
![]() Anabasis SRL Miscellaneous Commercial ServicesCommercial Services Part of Dompé SpA, Anabasis SRL provides biopharmaceutical research and development services. The company is based in Milan, Italy. The Italian company was founded by Francesco Sinigaglia. Anabasis was acquired by Dompé SpA on February 27, 2012. | Miscellaneous Commercial Services | Founder | |
Mimetogen Pharmaceuticals, Inc.
![]() Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Founder | |
University of London | College/University | Undergraduate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Bausch Health Americas, Inc.
![]() Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
Sigma Chemicals Co.
![]() Sigma Chemicals Co. Chemicals: Major DiversifiedProcess Industries Sigma Chemicals Co. is an American company that manufactures chemicals. | Chemicals: Major Diversified | Sales & Marketing | |
SemaThera, Inc.
![]() SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Biotechnology | Chief Executive Officer | |
The Foundation Fighting Blindness, Inc.
![]() The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Foundation Fighting Blindness Clinical Research Institute
![]() Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Financial Conglomerates | Chief Executive Officer | |
ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
Alcon Laboratories, Inc.
![]() Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal |
Statistiques
Internationale
Italie | 6 |
Etats-Unis | 6 |
Canada | 4 |
Royaume-Uni | 2 |
Allemagne | 2 |
Sectorielle
Health Technology | 8 |
Commercial Services | 5 |
Consumer Services | 4 |
Process Industries | 2 |
Finance | 2 |
Opérationnelle
Director/Board Member | 5 |
Chief Executive Officer | 5 |
President | 4 |
Founder | 3 |
Chairman | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Rafi Kazandjian
- Connexions Sociétés